The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
Hoffmann-La Roche
Boehringer Ingelheim
ViroMissile, Inc.
Pfizer
Pfizer
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
SystImmune Inc.
Daiichi Sankyo
Adela, Inc
Second Life Therapeutics
AgonOx, Inc.
Eli Lilly and Company
Varian, a Siemens Healthineers Company
Novartis
Sichuan Baili Pharmaceutical Co., Ltd.
Var2 Pharmaceuticals
Elephas
Inhibrx Biosciences, Inc
Varian, a Siemens Healthineers Company
Seagen Inc.
VM Oncology, LLC
Takeda
Tempus AI
Massive Bio, Inc.
Eli Lilly and Company
Chongqing Precision Biotech Co., Ltd
LigaChem Biosciences, Inc.
Travera Inc
A2 Biotherapeutics Inc.
Incyte Corporation
Incyte Corporation
Turning Point Therapeutics, Inc.
Marengo Therapeutics, Inc.
Apollomics Inc.
Hoffmann-La Roche
Compugen Ltd
Tempus AI
Revolution Medicines, Inc.
Elevation Oncology
Labcorp Corporation of America Holdings, Inc
Intensity Therapeutics, Inc.
Checkpoint Therapeutics, Inc.
NextCure, Inc.
Pack Health
Travera Inc
VitaMed Research LLC
Inhibrx Biosciences, Inc
NantCell, Inc.